Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in France / NCT06986980
Recruiting Observational

Intestinal Microsporidiosis in French Heart Transplant Recipients (CARMIC)

NCT06986980 · tracked via the Priya Life Science France tracker
Sponsor
University Hospital, Clermont-Ferrand
Phase
Observational
Started
2025-05-05
Last updated
2025-07-01

Condition(s) studied

Microsporidiosis IntestinalHeart Transplant Infection

Study summary

The investigators propose to carry out a national retrospective study to collect epidemiological, biological, clinical and therapeutic data on microsporidiosis among heart transplant patients.

Eligibility

Sex
ALL
Min age
—
Max age
—
Healthy volunteers
No
Inclusion Criteria: * heart transplant patients diagnosed with intestinal microsporidiosis * diagnosis made before December 31, 2024 in France (metropolitan France and overseas territories) Exclusion Criteria: -patient opposition

Primary outcome measure(s)

  • Demographic data: age — 1 year
    expressed in years old
  • Demographic data: sex — 1 year
    choice between: male/female
  • Time between transplant and microsporidiosis — 1 year
    expressed in days, or years if \>365 days
  • At diagnosis: number of days since the onset of symptoms — 1 year
    expressed in number of days
  • Weight loss at diagnosis — 1 year
    expressed in kilogram or in percent (compared to usual weight of the patient)
  • Dosage of immunosuppressants at diagnosis — 1 year
  • Time to stool negativation — 1 year
    expressed in number of days between onset of treatment and first negative PCR during follow-up
  • Creatinine level in blood at Day 0 (diagnosis) and Month 3 — 3 months
    expressed in µM
  • Numeration of cells in blood: platelets, lymphocytes, neutrophils at Day 0 (diagnosis) and Month 3 — 3 months
    expressed in Giga per litre
  • Gammaglobulins in blood at diagnosis — 1 year
    expressed in gram per litre

Trial sites (1)

FacilityCityRegionStatus
CHU Gabriel Montpied Clermont-Ferrand France Recruiting

More University Hospital, Clermont-Ferrand trials in France

Interest of an Attentional Evaluation by a Computerized Battery in the Management of Concussion in Young Rugby Players Recruiting
Effect of APA on Sleep Quality in Children With Cancer From 5 to 16 Years Recruiting
CO2 Modulation in Endovascular Thrombectomy for Acute Ischemic Stroke Recruiting
Evaluation of the Relationship Between Muscle Mass Measured by Bioelectrical Impedance Analysis and the Risk of Hemorrhagic Events Under Direct Oral Anticoagulants in the Elderly Starting soon
Preservation of Women's Fertility: Evaluation of Innovative Methods for Ovarian Tissue Cryopreservation Active, not recruiting

Other trials for the same condition

Complications in Pediatric Mechanical Circulatory Assistance: Evaluation of Infection Management. Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06986980 on ClinicalTrials.gov ↗ ← All trials in France